Table 3:

Demographic and travel characteristics according to route of vaccine administration

VariableRoute; no. of travellers (% of category)*Standardized difference (95% CI)
Intradermal
n = 941
Intramuscular
n = 780
Age, mean ± SD; yr34.60 ± 15.1537.18 ± 15.02−0.171 (−0.266 to −0.076)
Age, yr−0.121 (−0.216 to −0.026)
 < 1860 (63.8)34 (36.2)
 18–40581 (55.6)463 (44.3)
 41–60246 (52.3)224 (47.6)
 > 6054 (47.8)59 (52.2)
Sex−0.097 (−0.191 to −0.002)
 Female535 (56.8)406 (43.1)
 Male406 (52.0)374 (47.9)
Travel duration, mean ± SD; wk16.85 ± 19.7016.44 ± 26.200.018 (−0.082 to 0.117)
Travel duration, wk0.153 (0.053 to 0.253)
 ≤ 4302 (50.2)300 (49.8)
 5–12208 (54.0)177 (46.0)
 13–24169 (66.8)84 (33.2)
 25–52156 (62.9)92 (37.1)
 > 5232 (44.4)40 (55.6)
 Missing74 (7.9)87 (11.2)
Continent0.274 (0.174 to 0.373)
 Africa129 (47.1)145 (52.9)
 Americas145 (44.2)183 (55.8)
 Asia610 (62.2)371 (37.8)
 Europe6 (42.8)8 (57.1)
 Missing51 (5.4)73 (9.4)
Reason for travel−0.361 (−0.460 to −0.262)
 Tourism696 (63.1)407 (36.9)
 Work/business40 (21.8)143 (78.1)
 Education/research38 (67.8)18 (32.1)
 Volunteer/aid work101 (39.6)154 (60.4)
 Visiting friends and relatives0 (0.0)2 (100.0)
 Missing66 (7.0)56 (7.2)
No. of travellers in group−0.166 (−0.264 to −0.067)
 1212 (51.4)200 (48.5)
 2388 (61.0)248 (39.0)
 ≥ 3285 (51.6)267 (48.4)
 Missing56 (6.0)65 (8.3)
  • Note: CI = confidence interval, SD = standard deviation.

  • * Except where noted otherwise.